Deborah Knobelman Kronos Bio, Inc. (KRON) insider trading activity

Deborah Knobelman is President & Interim CEO of Kronos Bio, Inc.. Currently has a direct ownership of 0 shares of KRON, which is worth approximately $0. The most recent transaction as insider was on Jun 20, 2025, when has been sold 139,422 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $79,470. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

DEBORAH KNOBELMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	SELL Disposition due to a tender of shares in a change of control transaction	$79,470 $0.57 p/Share	139,422 Reduced 100.0%	0 Common Stock
Jun 05 2025	SELL Open market or private sale	$21,609 $0.87 p/Share	24,838 Reduced 15.12%	139,422 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	164,260 Added 50.0%	164,260 Common Stock

Also insider at

SNTI

Senti Biosciences, Inc. Healthcare

Chief Financial Officer